Differential expression of drug resistance-related genes between sensitive and resistant blasts in acute myeloid leukemia

Acta Haematologica

Volumn 117, Issue 1, 2006, Pages 8-15

  Eisele, L ^a   Klein Hitpass, L ^a   Chatzimanolis, N ^a   Opalka, B ^a   Boes, T ^a   Seeber, S ^a   Moritz, T ^a   Flasshove, M ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Acute myeloid leukemia; Apoptosis resistance; CD34; Drug resistance; Gene expression

Indexed keywords

ANTHRACYCLINE; CYTARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLAST CELL; CANCER CHEMOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALVAGE THERAPY;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEOSIDES; NUCLEOTIDES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; REMISSION INDUCTION; RNA, NEOPLASM; SALVAGE THERAPY; SUPEROXIDES; TREATMENT OUTCOME; TUMOR STEM CELLS;

EID: 33845752996     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096854     Document Type: Article

References (31)

1. Tallman MS, Gilliland DG, Rowe JM: Drug therapy for acute myeloid leukemia. Blood 2005;106:1154-1163.
2. Stone RM, O'Donnell MR, Sekeres MA: Acute myeloid leukemia. Hematology (Am Soc Hematol Educ Program) 2004;98-117.
3. Gewirtz DA: A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 1999;57:727-741.
4. Leith CP, Kopecky KJ, Godwin J, McConnell T, Slovak ML, Chen IM, Head DR, Appelbaum FR, Willman CL: Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood 1997;89:3323-3329.
5. Leith CP, Chen IM, Kopecky KJ, Appelbaum FR, Head DR, Godwin JE, Weick JK, Willman CL: Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases. Blood 1995;86:2329-2342.
6. Galmarini CM, Mackey JR, Dumontet C: Nucleoside analogues: mechanisms of drug resistance and reversal strategies. Leukemia 2001;15:875-890.
7. Del Poeta G, Venditti A, Del Principe MI, Maurillo L, Buccisano F, Tamburini A, Cox MC, Franchi A, Bruno A, Mazzone C, Panetta P, Suppo G, Masi M, Amadori S: Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML). Blood 2003;101:2125-2131.
8. Flasshove M, Meusers P, Schutte J, Noppeney R, Beelen DW, Sohrab S, Roggenbuck U, Kemmeries G, Brittinger G, Seeber S, Scheulen ME: Long-term survival after induction therapy with idarubicin and cytosine arabinoside for de novo acute myeloid leukemia. Ann Hematol 2000;79:533-542.
9. Mandelli F, Vegna ML, Avvisati G, Amadori S, Spadea A, Cacciola E, Cantore N, De Laurenzi A, De Rosa C, Fioritoni G, Gabbas A, Liso V, Malleo C, Miraglia E, Montillo M, Perticone R, Peta A, Ricciuti F, Petti MC: A randomized study of the efficacy of postconsolidation therapy in adult acute nonlymphocytic leukemia: a report of the Italian Cooperative Group GIMEMA. Ann Hematol 1992;64:166-172.
10. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
11. Durig J, Nuckel H, Huttmann A, Kruse E, Holter T, Halfmeyer K, Fuhrer A, Rudolph R, Kalhori N, Nusch A, Deaglio S, Malavasi F, Moroy T, Klein-Hitpass L, Duhrsen U: Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia. Blood 2003;101:2748-2755.
12. R Development Core Team: R: a language and environment for statistical computing. Version 2.1.1 2005. http://www.r-project.org.
13. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-264.
14. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000;25:25-29.
15. Hollander M, Wolfe DA: Nonparametric Statistical Inference, ed 2. New York, Wiley, 1999.
16. Westfall PH, Young SS: Resampling-Based Multiple Testing: Examples and Methods for p Value Adjustment. New York, Wiley, 1993.
17. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-537.
18. Johnson NL, Kotz S, Kemp AW: Univariate Discrete Distributions, ed 2. New York, Wiley, 1992.
19. Suarez L, Vidriales MB, Garcia-Larana J, Sanz G, Moreno MJ, Lopez A, Barrena S, Martinez R, Tormo M, Palomera L, Lavilla E, Lopez-Berges MC, de Santiago M, de Equiza ME, Miguel JF, Orfao A: CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes. Clin Cancer Res 2004;10:7599-7606.
20. van Stijn A, van der Pol MA, Kok A, Bontje PM, Roemen GM, Beelen RH, Ossenkoppele GJ, Schuurhuis GJ: Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemia. Haematologica 2003;88:497-508.
21. Galmarini CM, Thomas X, Calvo F, Rousselot P, Rabilloud M, El Jaffari A, Cros E, Dumontet C: In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia. Br J Haematol 2002;117:860-868.
22. Schroder JK, Kirch C, Seeber S, Schutte J: Structural and functional analysis of the cytidine deaminase gene in patients with acute myeloid leukaemia. Br J Haematol 1998;103:1096-1103.
23. Schroder JK, Kirch C, Flasshove M, Kalweit H, Seidelmann M, Hilger R, Seeber S, Schutte J: Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitro. Leukemia 1996;10:1919-1924.
24. Jahns-Streubel G, Reuter C, Auf der Landwehr U, Unterhalt M, Schleyer E, Wormann B, Buchner T, Hiddemann W: Activity of thymidine kinase and of polymerase alpha as well as activity and gene expression of deoxycytidine deaminase in leukemic blasts are correlated with clinical response in the setting of granulocyte-macrophage colony-stimulating factor-based priming before and during TAD-9 induction therapy in acute myeloid leukemia. Blood 1997;90:1968-1976.
25. Mizutani H, Tada-Oikawa S, Hiraku Y, Kojima M, Kawanishi S: Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci 2005;76:1439-1453.
26. Oh YK, Lee TB, Choi CH: Anti-oxidant adaptation in the AML cells supersensitive to hydrogen peroxide. Biochem Biophys Res Commun 2004;319:41-45.
27. Lazo JS, Kuo SM, Woo ES, Pitt BR: The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs. Chem Biol Interact 1998;111-112:255-262.
28. Suarez L, Vidriales B, Garcia-Larana J, Lopez A, Martinez R, Martin-Reina V, Tormo M, Gonzalez-San Miguel JD, Lavilla E, Garcia-Boyero R, Orfao A, San Miguel JF: Multiparametric analysis of apoptotic and multidrug resistance phenotypes according to the blast cell maturation stage in elderly patients with acute myeloid leukemia. Haematologica 2001;86:1287-1295.
29. Huh YO, Smith TL, Collins P, Bueso-Ramos C, Albitar M, Kantarjian HM, Pierce SA, Freireich EJ: Terminal deoxynucleotidyl transferase expression in acute myelogenous leukemia and myelodysplasia as determined by flow cytometry. Leuk Lymphoma 2000;37:319-331.
30. Venditti A, Del Poeta G, Buccisano F, Tamburini A, Cox-Froncillo MC, Aronica G, Bruno A, Del Moro B, Epiceno AM, Battaglia A, Forte L, Postorino M, Cordero V, Santinelli S, Amadori S: Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia. Leukemia 1998;12:1056-1063.
31. Heuser M, Wingen LU, Steinemann D, Cario G, von Neuhoff N, Tauscher M, Bullinger L, Krauter J, Heil G, Dohner H, Schlegelberger B, Ganser A: Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemia. Haematologica 2005;90:1484-1492.